ORCID as entered in ROS

Select Publications
2025, 'Safety and efficacy of low-intensity versus standard monitoring following intravenous thrombolytic treatment in patients with acute ischaemic stroke (OPTIMISTmain): an international, pragmatic, stepped-wedge, cluster-randomised, controlled non-inferiority trial', Lancet, 405, pp. 1909 - 1922, http://dx.doi.org/10.1016/S0140-6736(25)00549-5
,2025, 'Traditional Chinese medicine for acute intracerebral haemorrhage – Authors' reply', Lancet, 405, pp. 1741 - 1742, http://dx.doi.org/10.1016/S0140-6736(25)00844-X
,2025, 'Interaction of brain imaging features and effects of intensive blood pressure lowering after endovascular treatment for acute ischaemic stroke: the pre-specified secondary analyses of ENCHANTED2/MT trial', Eclinicalmedicine, 83, http://dx.doi.org/10.1016/j.eclinm.2025.103197
,2025, 'Predictors of Early versus Delayed Neurological Deterioration after Thrombolysis for Ischemic Stroke', Cerebrovascular Diseases, 54, pp. 175 - 183, http://dx.doi.org/10.1159/000539322
,2025, 'Statistical Analysis Plan for the INTEnsive Ambulance-Delivered Blood Pressure Reduction in Hyper-ACute Stroke Trial', Cerebrovascular Diseases, 54, pp. 278 - 281, http://dx.doi.org/10.1159/000539503
,2025, 'Subacute Neurological Improvement Predicts Favorable Functional Recovery After Intracerebral Hemorrhage: INTERACT2 Study', Stroke, 56, pp. 621 - 627, http://dx.doi.org/10.1161/STROKEAHA.124.048847
,2025, 'Implementation of Low-Intensity Thrombolysis Monitoring Care in Routine Practice: Process Evaluation of the Optimal Post rtPA-IV Monitoring in Acute Ischemic Stroke Study in the USA', Cerebrovascular Diseases, 54, pp. 96 - 104, http://dx.doi.org/10.1159/000538136
,2025, 'Opinions over Targets for Blood Pressure Control after Mechanical Thrombectomy in Patients with Acute Ischemic Stroke: Baseline Survey for the ENCHANTED2/MT Trial in China', Cerebrovascular Diseases, 54, pp. 138 - 144, http://dx.doi.org/10.1159/000537924
,2025, 'A cautionary view on blood pressure lowering in patients with acute ischaemic stroke receiving reperfusion therapy', Lancet Neurology, 24, pp. 28 - 29, http://dx.doi.org/10.1016/S1474-4422(24)00438-1
,2025, 'Intensive Blood Pressure Lowering and Renal Function in Ischemic Stroke Patients: Secondary Analysis of the ENCHANTED Trial', Cerebrovascular Diseases, 53, pp. 703 - 710, http://dx.doi.org/10.1159/000536275
,2024, 'Implementation of a goal-directed Care Bundle for intracerebral hemorrhage: Results of embedded process evaluation in the INTERACT3 trial', Plos Global Public Health, 4, pp. e0003711, http://dx.doi.org/10.1371/journal.pgph.0003711
,2024, 'Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: a multicentre, randomised, placebo-controlled, double-blind, clinical trial', Lancet, 404, pp. 2187 - 2196, http://dx.doi.org/10.1016/S0140-6736(24)02261-X
,2024, 'The main Optimal Post rTpa-Iv Monitoring in Ischemic Stroke Trial (OPTIMISTmain): Protocol for a Pragmatic, Stepped Wedge, Cluster Randomized Controlled Trial', Cerebrovascular Diseases, 53, pp. 635 - 642, http://dx.doi.org/10.1159/000534706
,2024, 'Twenty-Four-Hour Post-Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study', Journal of the American Heart Association, 13, pp. e036109, http://dx.doi.org/10.1161/JAHA.124.036109
,2024, 'Efficacy and Safety of Chinese Herbal Medicine in Patients with Acute Intracerebral Hemorrhage: Protocol for a Randomized Placebo-Controlled Double-Blinded Multicenter Trial', Cerebrovascular Diseases, 53, pp. 501 - 508, http://dx.doi.org/10.1159/000534761
,2024, 'Promising Efforts to Define a Novel Approach to Neuroprotection for Acute Ischemic Stroke', JAMA Neurology, 81, pp. 317 - 318, http://dx.doi.org/10.1001/jamaneurol.2023.5727
,2024, 'Influence of renal function on blood pressure control and outcome in thrombolyzed patients after acute ischemic stroke: post-hoc analysis of the ENCHANTED trial', Frontiers in Endocrinology, 15, pp. 1341902, http://dx.doi.org/10.3389/fendo.2024.1341902
,2024, 'Lack of Consensus among Stroke Experts on the Optimal Blood Pressure Target of Acute Ischemic Stroke: Evidence from a National Survey', Cerebrovascular Diseases, http://dx.doi.org/10.1159/000543043
,2024, 'Optimum Baseline Clinical Severity Scale Cut Points for Prognosticating Intracerebral Hemorrhage: INTERACT Studies', Stroke, 55, pp. 139 - 145, http://dx.doi.org/10.1161/STROKEAHA.123.044538
,2024, 'Process Evaluation of an Ambulance-Delivered Early Intensive Blood Pressure-Lowering Stroke Trial: Design, Rationale, and Reflection', Cerebrovascular Diseases, http://dx.doi.org/10.1159/000541322
,2023, 'Anticoagulants for acute ischaemic stroke: a Cochrane review', Emergencias, 35, pp. 463 - 464
,2023, 'Update on the INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): progress and baseline features in 2053 participants', Trials, 24, pp. 817, http://dx.doi.org/10.1186/s13063-023-07861-5
,2023, 'The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial', Lancet, 402, pp. 27 - 40, http://dx.doi.org/10.1016/S0140-6736(23)00806-1
,2023, 'Trials in intracerebral haemorrhage: a path to success?', Lancet Neurology, 22, pp. 542 - 543, http://dx.doi.org/10.1016/S1474-4422(23)00201-6
,2023, 'Statistical Analysis Plan for the INTEnsive Care Bundle with Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial: A Stepped-Wedge Cluster Randomized Controlled Trial', Cerebrovascular Diseases, 52, pp. 251 - 254, http://dx.doi.org/10.1159/000526384
,2023, 'Cost-Effectiveness of Low-Dose Compared to Standard-Dose Alteplase for Acute Ischemic Stroke in China: A Within-Trial Economic Evaluation of the ENCHANTED Study', Cerebrovascular Diseases, 52, pp. 145 - 152, http://dx.doi.org/10.1159/000525869
,2023, 'Effects of intensive blood pressure lowering on cerebral ischaemia in thrombolysed patients: insights from the ENCHANTED trial', eClinicalMedicine, 57, pp. 101849, http://dx.doi.org/10.1016/j.eclinm.2023.101849
,2023, 'Increasing burden of stroke in China: A systematic review and meta-analysis of prevalence, incidence, mortality, and case fatality', International Journal of Stroke, 18, pp. 259 - 267, http://dx.doi.org/10.1177/17474930221135983
,2023, 'The prevalence of cardiometabolic multimorbidity and its associations with health outcomes among women in China', Frontiers in Cardiovascular Medicine, 10, http://dx.doi.org/10.3389/fcvm.2023.922932
,2022, 'Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial', Lancet, 400, pp. 1585 - 1596, http://dx.doi.org/10.1016/S0140-6736(22)01882-7
,2022, 'The challenges of large-scale prehospital stroke trials', The Lancet Neurology, 21, pp. 948 - 949, http://dx.doi.org/10.1016/S1474-4422(22)00356-8
,2022, 'Baseline blood pressure does not modify the effect of intravenous thrombolysis in successfully revascularized patients', Frontiers in Neurology, 13, pp. 984599, http://dx.doi.org/10.3389/fneur.2022.984599
,2022, 'The association between functional status and physical pain with depressive symptoms after a stroke event: A cross-sectional analysis of the China Health and Retirement Longitudinal Study 2018', Frontiers in Psychiatry, 13, pp. 927856, http://dx.doi.org/10.3389/fpsyt.2022.927856
,2022, 'Therapeutic Strategies for Intracranial Atherosclerosis', JAMA, 328, pp. 529 - 531, http://dx.doi.org/10.1001/jama.2022.11525
,2022, 'Anticoagulants for Acute Ischemic Stroke: Cochrane Review', Stroke, 53, pp. E385 - E387, http://dx.doi.org/10.1161/STROKEAHA.121.038015
,2022, 'Process Evaluation of an Implementation Trial: Design, Rationale, and Early Lessons Learnt From an International Cluster Clinical Trial in Intracerebral Hemorrhage', Frontiers in Medicine, 9, pp. 813749, http://dx.doi.org/10.3389/fmed.2022.813749
,2022, 'Implementing a Goal-Directed Care Bundle after Acute Intracerebral Haemorrhage: Process Evaluation for the Third INTEnsive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial Study in China', Cerebrovascular Diseases, 51, pp. 373 - 383, http://dx.doi.org/10.1159/000520669
,2022, 'Blood Pressure Management for Ischemic Stroke in the First 24 Hours', Stroke, 53, pp. 1074 - 1084, http://dx.doi.org/10.1161/STROKEAHA.121.036143
,2022, 'Associations of Early Systolic Blood Pressure Control and Outcome after Thrombolysis-Eligible Acute Ischemic Stroke: Results from the ENCHANTED Study', Stroke, 29, pp. 779 - 787, http://dx.doi.org/10.1161/STROKEAHA.121.034580
,2022, 'Stroke care and collaborative academic research in Latin America', Salud Publica De Mexico, 64, pp. 40 - 45, http://dx.doi.org/10.21149/12803
,2022, 'The second randomized controlled ENhanced Control of Hypertension ANd Thrombectomy strokE stuDy (ENCHANTED2): Protocol and progress', International Journal of Stroke, 18, http://dx.doi.org/10.1177/17474930221120345
,2022, 'Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress', International Journal of Stroke, 17, pp. 1156 - 1162, http://dx.doi.org/10.1177/17474930211068671
,2022, 'Efficacy and Safety of Additional S-1 Chemotherapy to S-1 Plus Oxaliplatin Regimen Chemotherapy for Stage III Gastric Carcinoma after Radical Resection.', Cancer Invest, 40, pp. 73 - 80, http://dx.doi.org/10.1080/07357907.2021.1988961
,2022, 'Fluid shear stress-induced down-regulation of microRNA-140-5p promotes osteoblast proliferation by targeting VEGFA via the ERK5 pathway.', Connect Tissue Res, 63, pp. 156 - 168, http://dx.doi.org/10.1080/03008207.2021.1891228
,2022, 'The acute paraquat poisoning mortality (APPM) score to predict the risk of death in paraquat-poisoned patients.', Clin Toxicol (Phila), 60, pp. 446 - 450, http://dx.doi.org/10.1080/15563650.2021.1979234
,2021, 'Atorvastatin combined with dexamethasone in chronic subdural haematoma (ATOCH II): study protocol for a randomized controlled trial', Trials, 22, pp. 905, http://dx.doi.org/10.1186/s13063-021-05871-9
,2021, 'INTEnsive ambulance-delivered blood pressure Reduction in hyper-ACute stroke Trial (INTERACT4): study protocol for a randomized controlled trial', Trials, 22, pp. 1 - 14, http://dx.doi.org/10.1186/s13063-021-05860-y
,2021, 'INTEnsive care bundle with blood pressure reduction in acute cerebral hemorrhage trial (INTERACT3): study protocol for a pragmatic stepped-wedge cluster-randomized controlled trial', Trials, 22, pp. 1 - 14, http://dx.doi.org/10.1186/s13063-021-05881-7
,2021, 'Anticoagulants for acute ischaemic stroke', Cochrane Database of Systematic Reviews, 2021, pp. cd000024, http://dx.doi.org/10.1002/14651858.CD000024.pub5
,2021, 'Disparities between Asian and Non-Asian Thrombolyzed Acute Ischemic Stroke Patients in the Enhanced Control of Hypertension and Thrombolysis Stroke Trial', Cerebrovascular Diseases, 50, pp. 560 - 566, http://dx.doi.org/10.1159/000516487
,